United Clinical Laboratory LLC

United Clinical Laboratory LLC was paid $668K by Medicaid between Aug 2019 and Jul 2023, across 31 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 61% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#53 of 225

Median peer was paid$74K

This provider vs. median9.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	5,185	$129K
2020	8,841	$304K
2021	6,782	$151K
2022	3,215	$55K
2023	906	$29K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	61%	7,779	2,063	$411K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	14%	1,084	929	$94K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	11%	1,686	1,081	$70K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.3%	2,022	1,445	$29K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.3%	2,018	1,441	$29K
80050	General health panel	1.6%	912	682	$11K
80074		1.4%	856	668	$9K
80061	Lipid panel	<1%	894	667	$4K
80053	Comprehensive metabolic panel	<1%	1,402	1,069	$3K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	891	515	$2K
84439		<1%	765	573	$2K
82248		<1%	817	627	$2K

19 more codes

86592		<1%	917	$1K
84703		<1%	122	$465.65
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	84	$391.66
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	797	$198.10
82565		<1%	730	$84.79
82247		<1%	783	$40.50
86803		<1%	53	$36.84
84460		0%	36	$0.00
84155		0%	36	$0.00
86694		0%	34	$0.00
84450		0%	36	$0.00
84100		0%	12	$0.00
81005		0%	13	$0.00
82040		0%	36	$0.00
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	0%	12	$0.00
84075		0%	36	$0.00
82607		0%	37	$0.00
83735		0%	12	$0.00
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVESSELOV, KIRILL (CEO)

Same official

Other billing entities under VESSELOV, KIRILL

Full network →

Provider	Location	Paid
United Clinical Laboratory of New Jersey LLC	Fairfield, NJ	$42.34

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.